Study 2 of 5Elamipretide literatureCell metabolismTop journal2026
Is an emerging pharmacotherapeutic era for rare mitochondrial diseases here?
Not reported in abstract.
Where it sits
this study against the rest of the elamipretide corpus2
Preclinical · this one
3
Observational
0
Open-label
0
Randomised
0
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.
Elsewhere in the Elamipretide corpus
BLipoprotein metabolism and inflammation in healthy young subjects - exploring the postprandial and postabsorptive phases following intake of a standardized meal.Atherosclerosis plus · 2026 · n=34 · 325% increase in IL-6 10 h after breakfast.HumanBPsychometric properties of the Arabic translation of the PTGI-SF 10-item scale in adolescents.European journal of psychotraumatology · 2026 · n=605 · ω = 0.73/α = 0.73HumanBClinical significance of soluble E-selectin and soluble vascular cell adhesion molecule-1 levels in umbilical cord blood for neonatal respiratory distress syndrome: a retrospective study.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2026 · n=558 · AUC for combined sE-selectin and sVCAM-1: 0.935.HumanDEarly-stage type 1 diabetes: is there a role for lifestyle modifications?The lancet. Diabetes & endocrinology · 2026—